Clene Inc. (CLNN)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NASDAQ
Market Cap: $56.45M
Last updated: Nov 17, 2026 at 4:22 PM ET
Clene Inc. (CLNN) Statistics
Clene (CLNN) has a market cap of $56.45M and an enterprise value of $65.78M. It kept -11271.43% of revenue as net income over the last 12 months. Its share count is up 42.63% from a year earlier.
Total Valuation
Enterprise value is 16.52% above the market cap, as debt exceeds cash.
| Market Cap | $56.45M |
|---|---|
| Enterprise Value | $65.78M |
| Latest price (Nov 17, 2026) | $3.22 |
Key Dates
The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 198.5x. Its year-end P/S ranged from 14.4x to 275.8x from 2022 to 2025.
| P/S Ratio | 198.5x |
|---|---|
| Forward P/S | 225.3x |
Price Statistics
The stock is down 62.21% over 52 weeks and trades 17.01% below its 50-day average.
| Beta (1Y) | 1.68 |
|---|---|
| 52-Week Change | -62.21% |
| 1-Month Change | -2.13% |
| 3-Month Change | -23.15% |
| 6-Month Change | -49.53% |
| 5-Year Change | -96.47% |
| Total Return (1Y) | -62.21% |
| Total Return (3Y CAGR) | -29.22% |
| Total Return (5Y CAGR) | -50.27% |
| Return vs SPY (1Y) | -73.94% |
| Max Drawdown (1Y) | -70.08% |
| Max Drawdown (3Y) | -78.26% |
| Sharpe Ratio (1Y) | -1.07 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $3.88 |
| 200-Day Average | $5.13 |
| 52-Week Range | $3.02 to $10.84 |
| RSI (14 Days) | 35.6 |
| Average Volume (20 Days) | 91.76K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.85x current liabilities.
| Current Ratio | 0.85x |
|---|---|
| Quick Ratio | 0.84x |
| Interest Coverage | -9.48x |
Returns and Efficiency
Return on invested capital is -492.72% over the last 12 months.
| Return on Assets (ROA) | -121.07% |
|---|---|
| Return on Invested Capital (ROIC) | -492.72% |
| ROA (5Y Average) | -93.15% |
| Asset Turnover | 0.01x |
| Inventory Turnover | 11.03x |
| Receivables Turnover | 0.39x |
| Cash Conversion Cycle | 123 days |
Scores
CLNN has an Altman Z-Score of -24.05, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -24.05 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $238.00K over the last 12 months is up 11.21% from the 12 months before.
| Revenue | $238.00K |
|---|---|
| Revenue Growth (YoY) | +11.21% |
| Gross Profit | -$192.00K |
| Operating Income | -$21.00M |
| Pretax Income | -$26.83M |
| Net Income | -$26.83M |
| Reported EPS (TTM) | -$1.57 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $9.89M |
|---|---|
| Total Debt | $19.21M |
| Net Debt | $9.33M |
| Net Debt Per Share | $0.64 |
| Working Capital | -$2.62M |
| Shareholder Equity | -$14.81M |
| Total Assets | $22.16M |
| Total Liabilities | $36.97M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $80.03K of capital spending, operating cash flow left -$16.63M of free cash flow.
| Operating Cash Flow | -$16.55M |
|---|---|
| Capital Expenditures | $80.03K |
| Free Cash Flow | -$16.63M |
| FCF Per Share | -$1.15 |
| Depreciation and Amortization | $1.58M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -8823.11%.
| Gross Margin | -80.67% |
|---|---|
| Operating Margin | -8823.11% |
| Pretax Margin | -11271.43% |
| Net Margin | -11271.43% |
| FCF Margin | -6986.93% |
| Gross Margin (5Y Average) | 78.81% |
Growth
Revenue fell 24.94% a year over 3 years.
| Revenue Growth (3Y CAGR) | -24.94% |
|---|---|
| Revenue Growth (5Y CAGR) | -0.59% |
Stock Splits
The last split was a 1-for-20 reverse split on Jul 11, 2024.
| Last Split Date | Jul 11, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Peer Position
Against 8 similar companies, CLNN has the highest P/S.
P/S RatioPeer median 0.4x
ROICPeer median -4.60%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -1.36%
| P/S Ratio | 198.5x vs 0.4x median |
|---|---|
| ROIC | -492.72% vs -4.60% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +11.21% vs -1.36% median |
Analyst Forecast
Consensus estimates put revenue growth at 978.56% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +978.56% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CLNN
What is CLNN's market cap?
Clene has a market cap of $56.45M. Its enterprise value, which adds debt and subtracts cash, is $65.78M.
How many shares of CLNN are outstanding?
Clene has 14.67M shares outstanding. The count is up 42.63% from a year earlier.
Does CLNN pay a dividend?
No. Clene does not pay a dividend.
How much debt does CLNN have?
Clene has $19.21M of total debt and $9.89M of cash and equivalents, a net debt position of $9.33M.
CLNN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors